Crescent Capital BDC (CCAP) Stock Price, News & Analysis

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Crescent Capital BDC in the last twelve months. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" CCAP shares.
View CCAP analyst ratings or view top-rated stocks.

2 brokerages have issued twelve-month target prices for Crescent Capital BDC's shares. Their CCAP share price targets range from $16.50 to $19.00. On average, they anticipate the company's stock price to reach $17.75 in the next year. This suggests a possible upside of 4.4% from the stock's current price.
View analysts price targets for CCAP or view top-rated stocks among Wall Street analysts.

Crescent Capital BDC's stock was trading at $17.38 on January 1st, 2024. Since then, CCAP stock has decreased by 2.2% and is now trading at $17.00.
View the best growth stocks for 2024 here.

Crescent Capital BDC saw a increase in short interest in the month of March. As of March 31st, there was short interest totaling 131,700 shares, an increase of 32.9% from the March 15th total of 99,100 shares. Based on an average daily volume of 94,900 shares, the days-to-cover ratio is presently 1.4 days.
View Crescent Capital BDC's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 8th 2024.
View our CCAP earnings forecast.

Crescent Capital BDC, Inc. (NASDAQ:CCAP) posted its earnings results on Wednesday, February, 21st. The company reported $0.61 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.57 by $0.04. The company earned $50 million during the quarter, compared to the consensus estimate of $47.99 million. Crescent Capital BDC had a net margin of 45.54% and a trailing twelve-month return on equity of 11.32%.

Crescent Capital BDC declared a quarterly dividend on Wednesday, March 27th. Stockholders of record on Friday, March 29th will be given a dividend of $0.41 per share on Monday, April 15th. This represents a $1.64 dividend on an annualized basis and a dividend yield of 9.65%. The ex-dividend date is Wednesday, March 27th.
Read our dividend analysis for CCAP.

Crescent Capital BDC (NASDAQ:CCAP) pays an annual dividend of $1.64 per share and currently has a dividend yield of 9.67%. CCAP has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio is 71.62%. This payout ratio is at a healthy, sustainable level, below 75%. Based on EPS estimates, CCAP will have a dividend payout ratio of 81.19% in the coming year. This indicates that the company may not be able to sustain their current dividend.
Read our dividend analysis for CCAP.

ETFs with the largest weight of Crescent Capital BDC (NASDAQ:CCAP) stock in their portfolio include Putnam BDC Income ETF (PBDC).Virtus Private Credit Strategy ETF (VPC).

Based on aggregate information from My MarketBeat watchlists, some companies that other Crescent Capital BDC investors own include NGL Energy Partners (NGL), Annaly Capital Management (NLY), Enterprise Products Partners (EPD), Macerich (MAC), OFS Capital (OFS), AGNC Investment (AGNC), Chimera Investment (CIM), Colony Capital (CLNY), Energy Transfer (ET) and New Residential Investment (NRZ).

Crescent Capital BDC's stock is owned by many different retail and institutional investors. Top institutional investors include Confluence Investment Management LLC (0.19%), Global Assets Advisory LLC (0.06%) and Hennion & Walsh Asset Management Inc. (0.05%). Insiders that own company stock include Erik G Barrios, Gerhard Lombard, Jason Breaux, Joseph Hanlon, Kirill Bouek, Raymond Barrios and V Prem Et Al Watsa.
View institutional ownership trends.

Shares of CCAP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.